Labcorp Holdings Inc. (LH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Core Insights - 2025 was a significant year for LabCorp, focusing on four core therapeutic areas: oncology, women's health, autoimmune, and neurology [2] - The company launched over 100 tests in 2025, with the majority targeting the identified therapeutic areas, which are expected to grow 2 to 3 times faster than the overall diagnostic market [2] Strategic Focus - LabCorp's strategic focus on specific therapeutic areas is aimed at capitalizing on growth opportunities within the diagnostic market [2] - The anticipated growth rate of 2 to 3 times faster than the rest of the market indicates a strong potential for revenue increase in these segments [2]